Connect with us

Healthcare

Amylyx Pharma’s IPO Lands $190M As ALS Drug Begins FDA Review

Published

on

It’s the first week of the new year, and the life sciences sector continued the IPO momentum of 2021 as Wall Street welcomed three new biotech companies. Here’s a look at the IPOs of Amylyx Pharmaceuticals, CinCor, and Vigil Neuroscience, which raised a combined $482 million to support work on drugs addressing neurodegenerative and cardiovascular disorders.

Source Here: medcitynews.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Healthcare

‘The Scientists, They’re Learning More’: a Defiant Biden Defends the CDC Amid Mounting Criticism

Published

on

WASHINGTON — President Biden on Wednesday defended the Centers for Disease Control and Prevention, amid mounting criticism of the agency’s repeated struggles to communicate basic public health guidance.

But instead of conceding that the agency is fundamentally flawed, or that his top health officials have underperformed, Biden attributed the communications issues to the ever-changing nature of the Covid-19 pandemic, and of science itself.

Read the rest…

Source: statnews.com

Continue Reading

Healthcare

Regenerative Med Biotech ProKidney Inks $825M Merger to Back CKD Cell Therapy

Published

on

ProKidney is going public in a SPAC merger that infuses the biotech with $825 million for Phase 3 tests and manufacturing of its autologous cell therapy for chronic kidney disease. More than slowing the decline in organ function, ProKidney says its cell therapy offers the potential to reverse injury caused by the condition.

Original Post: medcitynews.com

Continue Reading

Healthcare

Metabucks: Microsoft Offers $69 Billion to Buy Activision Blizzard

Published

on

By

Microsoft just announced its intention to buy video game developer, Activision Blizzard, for almost $70 billion. This has some people speculating about Microsoft’s future metaverse aspirations.

Source: choice.npr.org

Continue Reading

Trending

Top100Biz.com